Drugs / haMPC-Exos
haMPC-Exos
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04544215 | Jul 2020 → Dec 2024 | — | Ruijin Hospital | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | haMPC-Exos | “A Clinical Study of Allogeneic Human Adipose-derived Mesenchymal Progenitor Cell Exosomes (haMPC-Exos) Nebulizer for the Treatment of Carbapenem-resistant Gram-negative...” NCT04544215 ↗ |
| Known as | Allogeneic Human Adipose-derived Mesenchymal Progenitor Cell Exosomes | “A Clinical Study of Allogeneic Human Adipose-derived Mesenchymal Progenitor Cell Exosomes (haMPC-Exos) Nebulizer for the Treatment of Carbapenem-resistant Gram-negative...” NCT04544215 ↗ |
| Modality | Other / unclassified | “Mesenchymal stem/progenitor cell exosomes are nano-sized vesicles secreted by mesenchymal stem/progenitor cells under certain conditions” NCT04544215 ↗ |
| Route | Inhaled | “7 times aerosol inhalation of MPCs-derived exosomes” NCT04544215 ↗ |